Skip to main content
TipRanks
Go Ultimate75% OFF

Elan Corp. (6099) AI Stock Analysis

1 Followers
JP:6099

Elan Corp.

(TSE/TYO:6099)

Select Model
Rating:80Outperform
Price Target:JPY 864.00â–²(14.44% Upside)
Action:reiterated
Date:11/07/26

Strong financial stability from minimal debt and healthy cash flows, along with bullish technical signals from price trends and momentum indicators, are the key drivers of the score. Reasonable valuation adds further support.

Positive Factors
Consistent Revenue GrowthConsistent revenue expansion indicates durable demand and ongoing business scale-up. Continued growth provides a foundation for operating leverage, supports reinvestment in the care-facility platform, and can strengthen earnings capacity over the next several quarters.
Negative Factors
Margin CompressionThe decline in operating and net margins suggests that profitability is facing cost pressure or an unfavorable mix shift. If this pattern persists, further revenue growth may translate less efficiently into earnings and could constrain long-term profit expansion.

Elan Corp. (6099) vs. iShares MSCI Japan ETF (EWJ)

-10%-5%0%5%10%15%20%25%30%JP:6099+6.43%EWJ+11.78%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 45.65B
Dividend Yield
1.99%
Average Volume (3M)
93.80K
Price to Earnings (P/E)
13.4
Beta (1Y)
0.28
Revenue Growth
11.87%
EPS Growth
37.37%
Country
Japan
Employees
974
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Elan Corp. Business Overview & Revenue Model

Company Description

Elan Corporation operates within the healthcare sector, specializing in nursing and medical services. The company offers a rental and laundry service for crucial daily items such as clothing, towels, and diapers, primarily catering to patients in hos...

How the Company Makes Money

null

Elan Corp. Financial Statement Overview

Summary

Strong balance sheet with minimal debt and healthy cash flow generation, supported by consistent revenue growth, though minor profitability margin concerns exist.

Income Statement

75Positive

Balance Sheet

85Very Positive

Cash Flow

80Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue56.78B55.45B47.51B41.43B36.26B31.64B
Gross Profit12.28B11.87B10.72B9.75B9.03B7.88B
EBITDA5.64B5.59B4.49B3.85B3.53B2.92B
Net Income2.92B2.77B2.35B2.52B2.08B1.91B
Balance Sheet
Total Assets25.76B26.23B21.61B18.99B16.07B13.95B
Cash, Cash Equivalents and Short-Term Investments5.63B6.85B6.85B5.49B6.04B5.63B
Total Debt685.20M765.20M86.57M000
Total Liabilities10.83B11.55B9.10B8.18B7.08B6.46B
Stockholders Equity14.52B14.44B12.50B10.81B8.99B7.48B
Cash Flow
Free Cash Flow03.18B3.62B1.59B1.23B2.03B
Operating Cash Flow04.29B4.50B1.78B1.58B2.11B
Investing Cash Flow0-3.39B-2.23B-1.66B-624.51M-357.68M
Financing Cash Flow0-906.86M-849.53M-667.09M-552.96M-614.15M

Elan Corp. Technical Analysis

Technical Analysis SentimentPositive
Last Price755.00

Price Trends

50DMA733.54Positive
100DMA746.91Positive
200DMA733.01Positive

Market Momentum

MACD11.62Positive
RSI50.58Neutral
STOCH25.34Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6099, the sentiment is Positive. The current price of 755.00 is below the 20-day moving average (MA) of 755.45, above the 50-day MA of 733.54, and above the 200-day MA of 733.01, indicating a neutral trend. The MACD of 11.62 indicates Positive momentum. The RSI at 50.58 is Neutral, neither overbought nor oversold. The STOCH value of 25.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6099.

Elan Corp. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:6099 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6099JP:609980OutperformJPY 45.65B13.3723.06%1.99%11.87%37.37%
JP:6062JP:606273OutperformJPY 64.04B14.44―2.19%5.50%45.42%
JP:2373JP:237357NeutralJPY 5.18B18.02―4.42%4.76%-52.55%
JP:2425JP:242555NeutralJPY 2.50B28.24―3.34%-3.64%-66.52%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:7061JP:706149NeutralJPY 3.03B-28.40――6.75%-119.69%

* Healthcare Sector Average

Performance Comparison

-50%0%50%JP:6099JP:2373JP:2425JP:6062JP:7061Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:6099 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:6099Elan Corp.755.0045.646.43%
JP:2373Care Twentyone Corporation385.00-50.94-11.69%
JP:2425Care Service Co., Ltd.658.00-115.78-14.96%
JP:6062Charm Care Corporation1964.00727.3658.82%
JP:7061Japan Hospice Holdings Inc.357.00-924.94-72.15%

Elan Corp. Corporate Events

Elan Finalizes Terms for 12,000-Share Employee Stock Option Plan

Nov 5, 2026

Elan Corporation, listed on the Tokyo Stock Exchange’s Prime Market, announced the finalized terms of stock compensation-type share acquisition rights for company employees and directors and executive officers of subsidiaries. The program covers 120...

Elan Corp. Details Disaster-Relief Efforts After Kumamoto Earthquake

Oct 30, 2026

Elan Corp. operates in the support services sector, focusing on providing logistical assistance and relief-related supplies in times of emergency. The company leverages group-wide capabilities to deliver essential goods, such as drinking water, to af...

Elan Corp. lifts profits and reaffirms growth outlook for 2026

Oct 30, 2026

Elan Corporation reported solid growth for the nine months ended September 30, 2026, with net sales rising 10.5% year on year to ¥45.0 billion and operating profit climbing 31.2% to ¥4.0 billion. Net profit attributable to owners of the parent increa...

Elan Corp Boosts Stock Benefit Trust With New Share Acquisition Plan

Oct 21, 2026

Elan Corporation has approved an additional monetary contribution to its existing Stock Benefit Trust (J-ESOP), continuing an equity-based incentive plan for employees and executives. The new funding, totaling JPY 97,350,000, will be used by the trus...

Elan Launches Stock Compensation Options for Employees and Subsidiary Executives

Oct 21, 2026

Elan Corporation’s board has approved the issuance of its 5th Series share acquisition rights as stock compensation-type stock options to selected employees and subsidiary management. The program is designed to align management and staff with shareho...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026